Dechra Pharmaceuticals PLC | Ownership
Companies that own Dechra Pharmaceuticals PLC
Fidelity Management & Research Co.
10,072,432
9.84%
211,627
0.04%
08/21/2018
BlackRock Investment Management (UK) Ltd.
4,932,701
4.82%
232,399
0.06%
01/29/2018
Standard Life Investments Ltd.
4,683,118
4.58%
-182,590
0.31%
07/05/2018
Schroder Investment Management Ltd.
4,017,465
3.93%
-225,535
0.11%
08/14/2017
Aviva Investors Global Services Ltd.
3,902,307
3.81%
920,043
0.33%
08/14/2017
Capital Research & Management Co. (World Investors)
3,890,018
3.8%
-209,424
0.02%
08/14/2017
Legal & General Investment Management Ltd.
3,355,126
3.28%
-157,108
0.06%
08/14/2017
Hargreave Hale Ltd.
2,966,698
2.9%
96,012
1.28%
08/14/2017
Royal London Asset Management Ltd.
2,848,000
2.78%
-82,000
0.3%
08/01/2018
Kames Capital Plc
2,808,885
2.75%
-670,569
0.84%
09/03/2018
| Address |
Cheshire Business Park
Northwich Cheshire CW9 7UA
United Kingdom
|
|
Employees
|
- |
| Website |
http://dechra.com |
| Updated |
07/08/2019 |
| Dechra Pharmaceuticals PLC is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. |
